{"address1": "333 Lakeside Drive", "city": "Foster City", "state": "CA", "zip": "94404", "country": "United States", "phone": "650 574 3000", "fax": "650 522 5853", "website": "https://www.gilead.com", "industry": "Drug Manufacturers\u2014General", "industryDisp": "Drug Manufacturers\u2014General", "sector": "Healthcare", "longBusinessSummary": "Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Merck & Co, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.", "fullTimeEmployees": 17000, "companyOfficers": [{"maxAge": 1, "name": "Mr. Daniel P.  O'Day", "age": 58, "title": "Chairman & CEO", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 7267338, "exercisedValue": 0, "unexercisedValue": 9635551}, {"maxAge": 1, "name": "Mr. Andrew D. Dickinson", "age": 52, "title": "Exec. VP & CFO", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 2935112, "exercisedValue": 0, "unexercisedValue": 5436829}, {"maxAge": 1, "name": "Ms. Deborah H. Telman", "age": 57, "title": "Exec. VP of Corp. Affairs, Gen. Counsel & Corp. Sec.", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": 2323080, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Johanna  Mercier", "age": 52, "title": "Chief Commercial Officer", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 3322200, "exercisedValue": 0, "unexercisedValue": 3864125}, {"maxAge": 1, "name": "Dr. Merdad V. Parsey M.D., Ph.D.", "age": 59, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 3074714, "exercisedValue": 0, "unexercisedValue": 3047349}, {"maxAge": 1, "name": "Ms. Sandra  Patterson", "age": 55, "title": "Sr. VP, Corp. Controller & Principal Accounting Officer", "yearBorn": 1967, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jacquie  Ross C.F.A.", "title": "VP of Investor Relations", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jyoti K. Mehra", "age": 46, "title": "Exec. VP of HR", "yearBorn": 1976, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael  Quigley Ph.D.", "title": "Sr. VP of Research Biology", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Linda Slanec Higgins Ph.D.", "age": 60, "title": "Sr. VP & Head of External Innovation", "yearBorn": 1962, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 2, "boardRisk": 5, "compensationRisk": 3, "shareHolderRightsRisk": 1, "overallRisk": 1, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 2, "previousClose": 78.8, "open": 78.77, "dayLow": 77.1699, "dayHigh": 78.84, "regularMarketPreviousClose": 78.8, "regularMarketOpen": 78.77, "regularMarketDayLow": 77.1699, "regularMarketDayHigh": 78.84, "dividendRate": 3.0, "dividendYield": 0.0381, "exDividendDate": 1686700800, "payoutRatio": 0.6652, "fiveYearAvgDividendYield": 3.85, "beta": 0.398662, "trailingPE": 17.712019, "forwardPE": 10.87883, "volume": 4926972, "regularMarketVolume": 4926972, "averageVolume": 5520103, "averageVolume10days": 5762180, "averageDailyVolume10Day": 5762180, "bid": 0.0, "ask": 0.0, "bidSize": 1100, "askSize": 800, "marketCap": 97430511616, "fiftyTwoWeekLow": 57.17, "fiftyTwoWeekHigh": 89.74, "priceToSalesTrailing12Months": 3.6027997, "fiftyDayAverage": 81.3172, "twoHundredDayAverage": 76.88075, "trailingAnnualDividendRate": 2.94, "trailingAnnualDividendYield": 0.037309643, "currency": "USD", "enterpriseValue": 116954390528, "profitMargins": 0.20645, "floatShares": 1245843392, "sharesOutstanding": 1247350016, "sharesShort": 19278956, "sharesShortPriorMonth": 15475585, "sharesShortPreviousMonthDate": 1680220800, "dateShortInterest": 1682640000, "sharesPercentSharesOut": 0.0155, "heldPercentInsiders": 0.00096000003, "heldPercentInstitutions": 0.85975, "shortRatio": 3.65, "shortPercentOfFloat": 0.0173, "impliedSharesOutstanding": 0, "bookValue": 16.825, "priceToBook": 4.642496, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1680220800, "earningsQuarterlyGrowth": 52.158, "netIncomeToCommon": 5583000064, "trailingEps": 4.41, "forwardEps": 7.18, "pegRatio": 5.16, "lastSplitFactor": "2:1", "lastSplitDate": 1359331200, "enterpriseToRevenue": 4.325, "enterpriseToEbitda": 9.387, "52WeekChange": 0.30118895, "SandP52WeekChange": 0.046755195, "lastDividendValue": 0.75, "lastDividendDate": 1678752000, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "GILD", "underlyingSymbol": "GILD", "shortName": "Gilead Sciences, Inc.", "longName": "Gilead Sciences, Inc.", "firstTradeDateEpochUtc": 696090600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "8659e669-8ec5-3b0f-9929-db5db506231f", "messageBoardId": "finmb_29002", "gmtOffSetMilliseconds": -14400000, "currentPrice": 78.11, "targetHighPrice": 115.0, "targetLowPrice": 77.0, "targetMeanPrice": 91.17, "targetMedianPrice": 90.0, "recommendationMean": 2.5, "recommendationKey": "buy", "numberOfAnalystOpinions": 24, "totalCash": 6518000128, "totalCashPerShare": 5.225, "ebitda": 12458999808, "totalDebt": 25238999040, "quickRatio": 1.014, "currentRatio": 1.278, "totalRevenue": 27043000320, "debtToEquity": 120.536, "revenuePerShare": 21.578, "returnOnAssets": 0.10245, "returnOnEquity": 0.27111, "grossProfits": 21624000000, "freeCashflow": 8514250240, "operatingCashflow": 8976000000, "earningsGrowth": 51.844, "revenueGrowth": -0.036, "grossMargins": 0.79166, "ebitdaMargins": 0.46071, "operatingMargins": 0.37869, "financialCurrency": "USD", "trailingPegRatio": 0.5725}